- 2023 Multidisciplinary Oncology Review
- 2022
- Videos
- 2021
- 2020
- 2019
- Hematology & Medical Oncology Review 2019
- 2018
- Events
Playback speed
10 seconds
EHA 2024 Insights: Golcadomide, an Oral CELMoD, + R-CHOP in Patients With Untreated Aggressive B-Cell Lymphoma
By
Insights from 2024 EHA Annual Meeting
FEATURING
Marc Hoffmann
By
Insights from 2024 EHA Annual Meeting
FEATURING
Marc Hoffmann
32 views
July 18, 2024
Comments 0
Login to view comments.
Click here to Login